The effect of quinapril on the aortic contractile response of streptozotocin-diabetic rats

Iranian Biomedical Journal

Volumn 7, Issue 4, 2003, Pages 173-177

  Dehkordi, Farshad Roghani ^a   Roghani, Mehrdad ^b   Mojarad, Tourandokht Baluchnejad ^c  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aortic reactivity; Diabetes mellitus; Quinapril; Rat; STZ

Indexed keywords

PHENYLEPHRINE; QUINAPRIL; STREPTOZOCIN; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; HEART MUSCLE CONTRACTILITY; MALE; NONHUMAN; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; VASCULAR RING;

RATTUS NORVEGICUS;

EID: 16244412683     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Malik, R.A. (2000) Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors? Ann. Med. 32: 1-5.
2. Uemura, S., Matsushita, H., Li, W., Glassford, A.J., Asagami, T., Lee, K.H., Harrison, D.G. and Tsao, P.S. (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 88: 1291-1298.
3. Senses, V., Ozyazgan, S., Ince, E., Tuncdemir, M., Kaya, F., Ozturk, M., Sultuybek, G. and Akkan, A.G. (2001) Effect of 5-aminoimidazole-4-carboxamide riboside (AICA-r) on isolated thoracic aorta responses in streptozotocin- diabetic rats. J. Basic Clin. Physiol. Pharmacol. 12: 227-248.
4. Vinik, A.I. and Vinik, E. (2003) Prevention of the complications of diabetes. Am. J. Manag. Care. 9: S63-80.
5. Kirpichnikov, D., Winer, N. and Sowers, J.R. (2002) The use of ACE inhibitors on diabetic patients without renal disease. Curr. Diab. Rep. 2: 21-25.
6. Schalkwijk, C.G., Smulders, R.A., Lambert, J., Donker, A.J. and Stehouwer C.D. (2000) ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients. Eur. J. Clin. Invest. 30: 853-860.
7. Van Gilst, W.H., de Graeff, P.A., Wesseling, H. and de Langen, C.D.J. (1986) Reduction of reperfusion arrhythmias in the ischemic isolated heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril and HOE 498. Cardiovasc. Pharmacol. 8: 722-728.
8. Chopra, M., Beswick, H., Clapperton, M., Dargie, H.J., Smith, W.E. and Mc Murray, J. (1992) Antioxidant effects of angiotensin-converting (ACE) inhibitors: free radical and antioxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl- containing ACE inhibitors. J. Cardiovasc. Pharmacol. 19: 330-340.
9. Onozato, M.L., Tojo, A., Goto, A., Fujita, T. and Wilcox, C.S. (2002) Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 61:186-194.
10. Kaplan, H.R., Taylor, D.G. and Olson, S.C. (1990) Quinapril: overview of preclinical data. Clin. Cardiol. 13: VII6-12.
11. Manzato, E., Capurso, A. and Crepaldi, G. (1993) Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril. J. Int. Med. Res. 21: 15-25.
12. Culy, C.R. and Jarvis, B. (2002) Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders. Drugs 62: 339-385.
13. Mullen, M.J., Clarkson, P., Donald, A.E., Thomson, H., Thorne, S.A., Powe, A.J., Furuno, T., Bull, T. and Deanfield, J.E. (1998) Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. J. Am. Coll. Cardiol. 31: 1330-1335.
14. Abebe, W., Harris, K.H. and Macleod, K.M. (1990) Enhanced contractile responses of arteries from diabetic rats to adrenoceptor stimulation in the absence and presence of extracellular calcium. J. Cardiovas. Pharmacol. 16: 239-248.
15. Baynes, J.W. (1992) Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
16. Ozturk, Y., Altan, V.M. and Yidizoglu-Ari, N. (1996) Effects of experimental diabetes and insulin on smooth muscle function. Pharmacol. Rev. 48: 69-112.
17. Auch-Schwelk, W., Duske, E., Claus, M., Graf, K., Grafe, M. and Fleck, E. (1995) Endothelium-mediated vasodilation during ACE inhibition. Eur. Heart J. 16: 59-65.
18. Kikta, D.C. and Fregly, M.J. (1982) Effect of in vitro administration of captopril on vascular reactivity of rat aorta. Hypertension 4: 118-124.
19. Ikeda, U. and Shimada, K. (1994) Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors. Eur. J. Pharmacol. 269: 319-323.
20. Kedziora-Kornatowska, K.Z., Luciak, M. and Paszkowski, J. (2000) Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. IUBMB Life 49: 303-307.
21. + fluxes in aortic smooth muscle. Hypertension 22: 806-811.
22. Hamdan, A.D., Quist, W.C., Gagne, J.B. and Feener, E.P. (1996) Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta. Circulation 93: 1073-1078.